Harbor Investment Advisory, LLC Vertex Pharmaceuticals Inc Transaction History

Harbor Investment Advisory, LLC

$1.26 Billion
Q4 2024

A detailed history of Harbor Investment Advisory, LLC transactions in Vertex Pharmaceuticals Inc stock. As of the latest transaction made, Harbor Investment Advisory, LLC holds 1,893 shares of VRTX stock, worth $857,907. This represents 0.06% of its overall portfolio holdings.

Number of Shares

1,893

Previous 2,208 14.27%

Holding current value

$857,907

Previous $1.03 Million 25.73%

% of portfolio

0.06%

Previous 0.09%

17 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Jan 16, 2025	SELL	$396.64 - $516.74 $124,941 - $162,773	-315 Reduced 14.27%	1,893 $762,000
Q3 2024 Oct 04, 2024	SELL	$460.0 - $505.78 $5,060 - $5,563	-11 Reduced 0.5%	2,208 $1.03 Million
Q2 2024 Jul 19, 2024	BUY	$392.81 - $485.53 $392 - $485	1 Added 0.05%	2,219 $1.04 Million
Q4 2023 Jan 26, 2024	BUY	$343.0 - $410.68 $450,702 - $539,633	1,314 Added 145.35%	2,218 $902,000
Q3 2023 Oct 13, 2023	BUY	$338.18 - $362.46 $16,909 - $18,123	50 Added 5.85%	904 $314,000
Q1 2023 Apr 21, 2023	SELL	$283.23 - $323.1 $56,646 - $64,620	-200 Reduced 18.98%	854 $269,000
Q4 2022 Jan 24, 2023	SELL	$285.76 - $321.48 $31,433 - $35,362	-110 Reduced 9.45%	1,054 $0
Q1 2022 Apr 20, 2022	BUY	$221.42 - $260.97 $33,213 - $39,145	150 Added 14.79%	1,164 $304,000
Q4 2021 Jan 10, 2022	BUY	$177.01 - $223.45 $140,899 - $177,866	796 Added 365.14%	1,014 $223,000
Q3 2021 Oct 12, 2021	SELL	$181.39 - $202.99 $79,267 - $88,706	-437 Reduced 66.72%	218 $40,000
Q2 2021 Jul 27, 2021	BUY	$187.49 - $221.1 $40,872 - $48,199	218 Added 49.89%	655 $132,000
Q1 2021 Apr 16, 2021	BUY	$207.02 - $241.31 $11,386 - $13,272	55 Added 14.4%	437 $94,000
Q4 2020 Feb 04, 2021	SELL	$207.01 - $276.09 $15,111 - $20,154	-73 Reduced 16.04%	382 $90,000
Q3 2020 Oct 23, 2020	SELL	$255.65 - $303.1 $171,541 - $203,380	-671 Reduced 59.59%	455 $124,000
Q2 2020 Jul 16, 2020	BUY	$225.48 - $295.8 $171,815 - $225,399	762 Added 209.34%	1,126 $327,000
Q1 2020 May 11, 2020	BUY	$199.77 - $247.81 $21,575 - $26,763	108 Added 42.19%	364 $87,000
Q4 2019 Jan 16, 2020	BUY	$166.71 - $223.91 $42,677 - $57,320	256 New	256 $56,000

Others Institutions Holding VRTX

# of Institutions

1,728

Shares Held

223M

Call Options Held

1.65M

Put Options Held

1.38M

View Full List

About VERTEX PHARMACEUTICALS INC

Ticker VRTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 256,691,008
Market Cap $116B
Description
Vertex Pharmaceuticals Incorporated, a biotechnology company, engages in developing and commercializing therapies for treating cystic fibrosis. The company markets SYMDEKO/SYMKEVI, ORKAMBI, and KALYDECO to treat patients with cystic fibrosis who have specific mutations in their cystic fibrosis transmembrane conductance regulator gene; and TRIKAF...

More about VRTX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Harbor Investment Advisory, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Harbor Investment Advisory, LLC with notifications on news.

Account

Harbor Investment Advisory, LLC Vertex Pharmaceuticals Inc Transaction History